Dispatch Bio

Develops engineered immunotherapies for patients with solid tumors

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-11-14

About Dispatch Bio

Dispatch Bio is developing the Flare platform, which combines immunotherapy with a tumor-specific virus to target solid tumors and address treatment resistance.

The company’s research and development facilities are in Philadelphia and San Francisco. Its team includes research, virology, clinical, and technical operations staff.

Product: The Flare platform, an engineered immunotherapy approach combining immunotherapy with a tumor-specific virus for solid tumors.

Jobs at Dispatch Bio

No open positions listed right now.

More biotech & pharma companies

  • Drug Hunter

    Drug discovery intelligence and research tools for pharmaceutical scientists, drug discovery teams and investors
    United StatesBiotech & pharma1 open job
    Remote-friendly
  • Dyne Therapeutics

    Targeted genetic therapies for people with genetically driven neuromuscular diseases
    Waltham, United StatesBiotech & pharmaFounded 2017
    New on Evolc
  • Dyno Therapeutics

    AI-enabled genetic technology development for biotechnology and medicine developers
    United StatesBiotech & pharma
    New on Evolc
  • Earli

    Develops genetic switches that activate in cancer cells for cancer detection and therapeutic applications
    United StatesBiotech & pharma
    New on Evolc
  • Editas Medicine

    Develops CRISPR-based genomic medicines for people living with serious diseases
    United StatesBiotech & pharma
  • Eisai

    Research-based pharmaceutical company developing oncology and neurology medicines for patients and healthcare providers
    United StatesBiotech & pharma
    New on Evolc

All biotech & pharma companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Analytics

  • Google Tag ManagerMedium confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Frontend frameworks

  • GatsbyMedium confidence
    First detected
    Last detected
    Last checked
    Detection evidence
  • ReactMedium confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Hosting

Privacy & consent

  • OsanoHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.